EMMA Mold Testing: Specialized Detection of Toxic Molds and Mycotoxins
Tailored for Health and Safety EMMA (environmental mold in mycotoxin assessment) tests house dust for 10 toxic molds and 50 mycotoxins and includes 30 minute consultation.
EMMA mold testing zeroes in on the most Clinically Significant Mold and Mycotoxins. It’s especially beneficial for individuals dealing with chronic health conditions, CIRS, or environmental sensitivities. Unlike broader tests like ERMI, EMMA offers detailed insights for those most vulnerable.
Reducing Remediation Costs Identifying the presence of toxic molds and mycotoxins is key. It significantly influences home remediation needs. If no mycotoxins are found, homeowners may bypass costly, comprehensive remediation. This targeted approach not only provides custom solutions but can also lead to significant cost savings in mold management.
EMMA’s Core Features
- Precise Mold Identification Using the MSQPCR method, EMMA precisely detects critical mold species such as Aspergillus, Penicillium, Chaetomium Globosum, Stachybotrys Chartarum, and Wallemia Sebi.
- Comprehensive Mycotoxin Screening The test thoroughly checks for a wide array of mycotoxins, including Aflatoxins, Gliotoxin, and Trichothecenes, noted for their severe health risks like immunosuppression and potential cancer links.
- Building Safety with HERTSMI-2 EMMA provides a HERTSMI-2 Score, essential for assessing the safety of a building. A score of ≤8 indicates a low-risk environment.
- Timely Report Delivery Detailed reports are provided within a 15-day timeframe.
- In-Depth Consultation A 30-minute expert consultation accompanies each test, helping with result analysis and providing guidance on health risk management, source identification, and remediation planning. Scheduling.
- Sampling can be a do-it-yourself or contact IES for on site sampling.